ASXL1 as a critical regulator of epigenetic marks and therapeutic potential of mutated cells

Daichi Inoue _, Takeshi Fujino and Toshio Kitamura

PDF  |  How to cite  |  Order a Reprint

Oncotarget. 2018; 9:35203-35204. https://doi.org/10.18632/oncotarget.26230

Metrics: PDF 991 views  |   ?  

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 26230